Related references
Note: Only part of the references are listed.Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers
Francois Chasset et al.
RHEUMATOLOGY (2020)
Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapse
Alexis Mathian et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Monitoring Disease Activity in Systemic Lupus Erythematosus With Single-Molecule Array Digital Enzyme-Linked Immunosorbent Assay Quantification of Serum Interferon-
Alexis Mathian et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
Munther Khamashta et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases
John C. Hall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
L Bennett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Share Paper
